Zacks Research Comments on Maximus, Inc.’s Q2 2024 Earnings (NYSE:MMS)

Maximus, Inc. (NYSE:MMS) – Analysts at Zacks Research upped their Q2 2024 earnings per share estimates for Maximus in a report released on Tuesday, April 23rd. Zacks Research analyst R. Department now anticipates that the health services provider will post earnings of $1.33 per share for the quarter, up from their prior estimate of $1.31. The consensus estimate for Maximus’ current full-year earnings is $5.41 per share. Zacks Research also issued estimates for Maximus’ Q4 2024 earnings at $1.38 EPS, FY2024 earnings at $5.39 EPS, Q3 2025 earnings at $1.35 EPS, Q4 2025 earnings at $1.42 EPS and Q2 2026 earnings at $1.06 EPS.

Maximus (NYSE:MMS) last posted its earnings results on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.06. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The company had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the previous year, the business earned $0.94 earnings per share. The company’s revenue for the quarter was up 6.2% on a year-over-year basis.

Other equities research analysts also recently issued research reports about the company. Raymond James downgraded Maximus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 3rd. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th.

Maximus Price Performance

NYSE:MMS opened at $80.98 on Wednesday. Maximus has a 52 week low of $72.39 and a 52 week high of $89.69. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $4.94 billion, a P/E ratio of 26.81 and a beta of 0.72. The stock’s fifty day moving average is $82.64 and its two-hundred day moving average is $81.26.

Institutional Investors Weigh In On Maximus

Hedge funds have recently bought and sold shares of the stock. Verdence Capital Advisors LLC increased its stake in shares of Maximus by 3.2% during the fourth quarter. Verdence Capital Advisors LLC now owns 4,563 shares of the health services provider’s stock worth $383,000 after buying an additional 140 shares during the period. VisionPoint Advisory Group LLC increased its position in shares of Maximus by 61.4% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 145 shares during the last quarter. Bridge City Capital LLC increased its position in shares of Maximus by 0.8% in the 1st quarter. Bridge City Capital LLC now owns 24,182 shares of the health services provider’s stock valued at $2,029,000 after purchasing an additional 188 shares during the last quarter. Retirement Systems of Alabama raised its holdings in shares of Maximus by 0.3% in the 4th quarter. Retirement Systems of Alabama now owns 76,128 shares of the health services provider’s stock valued at $6,384,000 after purchasing an additional 232 shares in the last quarter. Finally, Arizona State Retirement System lifted its position in shares of Maximus by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 17,307 shares of the health services provider’s stock worth $1,292,000 after purchasing an additional 237 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Insider Buying and Selling

In other Maximus news, CFO David Mutryn sold 8,000 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the transaction, the chief financial officer now owns 5,124 shares of the company’s stock, valued at approximately $430,159.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.40% of the stock is owned by insiders.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date of this dividend is Tuesday, May 14th. Maximus’s dividend payout ratio (DPR) is currently 39.74%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.